A detailed history of Xxec, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Xxec, Inc. holds 99,075 shares of NVO stock, worth $4.8 Million. This represents 5.16% of its overall portfolio holdings.

Number of Shares
99,075
Previous 78,185 26.72%
Holding current value
$4.8 Million
Previous $5.4 Million 1.87%
% of portfolio
5.16%
Previous 4.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 26, 2025

BUY
$45.38 - $71.7 $947,988 - $1.5 Million
20,890 Added 26.72%
99,075 $5.5 Million
Q2 2025

Aug 13, 2025

BUY
$58.08 - $81.05 $1.26 Million - $1.76 Million
21,756 Added 38.55%
78,185 $5.4 Million
Q1 2025

Apr 09, 2025

BUY
$69.3 - $90.95 $2.64 Million - $3.47 Million
38,102 Added 207.9%
56,429 $3.92 Million
Q4 2024

Feb 06, 2025

BUY
$85.0 - $120.04 $1.56 Million - $2.2 Million
18,327 New
18,327 $1.58 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Xxec, Inc. Portfolio

Follow Xxec, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xxec, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xxec, Inc. with notifications on news.